Skip to content
Back to Top

Prescription Drug
Monitoring Program

Prescription Drug Monitoring Program

The Alaska Prescription Drug Monitoring Program (PDMP) is Alaska's solution for monitoring Schedule II-IV controlled substances dispensed in Alaska. This program is designed to improve patient care and to encourage cooperation and coordination among state, local, and federal agencies and other states to reduce the misuse, abuse, and diversion of controlled substances. The controlled substance prescription database “PDMP” is delivered through the AWARxE platform and can be accessed by clicking here: You’ll find helpful information and resources in the links below and in the sidebar located to the right of this page.

** Statewide Gateway Integration **

The division is now offering statewide Gateway Integration to all health care entities in Alaska, at no cost! Please see the Gateway Integration page for more information on how facilities can integrate with the PDMP.


Mandatory Registration with the Alaska Prescription Drug Monitoring Program (PDMP) applies to actively licensed practitioners who hold a federal Drug Enforcement Administration registration number valid to use in any state and pharmacists who dispense federally scheduled II – IV controlled substances in the state. Please see below for the statutory authority compelling mandatory registration for each profession:

  • Dental (AS 08.36.070(a)(10))
  • Medical (AS 08.64.101(a)(7))
  • Nursing (AS 08.68.100(a)(11))
  • Optometry (AS 08.72.060(c)(3))
  • Practitioners and Pharmacists (AS 17.30.200(d)(3)(4) and AS 17.30.200(o))

Registration Instructions & Forms

IHS, VA, Military Registration Instructions

Use and Exemptions

Contact Information

PDMP Registration Status

Prescribing boards process PDMP registrations for their respective licensees. Please contact your licensing board for assistance with registration. To better assist you, we advise providing the license number that you are referencing.

PDMP Subpoena or Data Inquiries

Prescription Drug Monitoring Program
Board of Pharmacy